Fatigue related breast cancer.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients women with Breast cancer Having at least 18 years and maximum 80 years Having symptoms of fatigue Having at least 8 g/dl Hemoglobin Having at least 30% Hematocrit Having at least 2mg/dl Billy Rubin Having at least 2mg/dl Creatinine Having normal TSH
Exclusion criteria
Exclusion criteria: Severe Hb drop during study Severe Platelets and white blood cell loss during the study change of treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue severity score based on fatigue eye scale criterion. Timepoint: Zero and 4 weeks after treatment. Method of measurement: Fatigue Eye Scale Criterion Questionnaire.;Fatigue severity score. Timepoint: Zero and 4 weeks after treatment. Method of measurement: Fatigue severity scale questionnaire.;Cancer Fatigue Scale Score. Timepoint: Zero and 4 weeks after treatment. Method of measurement: Cancer Fatigue Scale Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences